Home>Topics>Companies>Zimmer Holdings

Zimmer Holdings ZMH

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
    1. Medtronic: Benefits Of Covidien Acquisition Not Enough To Make It A Buy

      Headlines

      Wed, 10 Sep 2014

      Description: Medtronic Inc. is a global medical device manufacturer has leadership positions in the pacemaker, defibrillator, orthopedic , diabetes management and other medical markets. Fair Value: In calculating fair value, I consider the NPV MMA Differential

    2. EU competition watchdog to decide on Zimmer , Biomet deal by early next month

      Headlines

      Mon, 1 Sep 2014

      Zimmer Holdings (NYSE: ZMH ) will hear back from EU antitrust authorities by Oct. 3 ..... to pursue its $13.4B takeover of rival Biomet (Pending: BMET ). Zimmer originally sought approval in June, but the EU regulator paused the review

    3. EU decision on Zimmer's $13.4 bln Biomet deal expected by Oct. 3

      Headlines

      Mon, 1 Sep 2014

      BRUSSELS, Sept 1 (Reuters) - European Union antitrust regulators will decide by Oct. 3 whether to give the green light to U.S. orthopaedic products maker Zimmer Holdings ' $13.4 billion takeover of...

    4. J & J unit recalls orthopedic implant

      Headlines

      Thu, 28 Aug 2014

      Johnson & Johnson's ( JNJ -0.3% ) DePuy Synthes unit recalls certain lots of its Craniomaxillofacial Distraction System also called External Mandibular Fixator and/or Distractor and a Bone Plate. The lots are being recalled due to the risk of the device reversing direction and losing the desired ...

    5. Zimmer Holdings declares $0.22 dividend

      Headlines

      Tue, 26 Aug 2014

      Zimmer Holdings (NYSE: ZMH ) declares $0.22/share quarterly dividend , in line with previous. Forward yield 0.88% Payable Oct. 31; for shareholders of record Sept. 26; ex-div Sept. 24. Post your comment!

    6. New Analyst Report for MSB

      Stock Reports

      Tue, 26 Aug 2014

      product. The most advanced of Mesoblast's clinical trial programs are targeting cardiovascular, bone marrow replacement and orthopedic diseases. Mesoblast is also targeting other disease areas such as diabetes, Alzheimer's and macular degeneration. Valuation

    7. CR Bard Bolsters Narrow Moat With Technology That Appeals to Hospitals Seeking Efficiencies

      Commentary

      Mon, 25 Aug 2014

      have less influence on brand decisions compared with highly engineered, implantable devices. Unlike St. Jude Medical and Zimmer 's devices, Bard's products are generally more vulnerable to pricing pressure. However, Bard's products are also typically

    8. BRIEF-Episurf Medical signed an agreement with orthopedic specialist clinic

      Headlines

      Fri, 22 Aug 2014

      Aug 22 (Reuters) - Episurf Medical AB : * Says signed an agreement with the orthopedic specialist clinic Sportsmedicine Umeå * Source text for Eikon * Further company coverage

    9. Week In Review: PW Medtech Pays $130 Million For Fellow China Medical Device Company

      Headlines

      Mon, 11 Aug 2014

      which makes regenerative medical biological materials and orthopedic implant products. In November 2013, PW Medtech staged a ..... Hong Kong. PW Medtech's existing business is centered on orthopedic implants and infusion equipment. Walvax Biotechnology (SHE

    10. UPDATE 1-Symmetry Medical to sell orthopedic component business for $450 mln

      Headlines

      Mon, 4 Aug 2014

      Aug 4 (Reuters) - Symmetry Medical Inc said it would sell its orthopedic device component business to privately held Tecomet Inc for $450 million.

    « Prev12345Next »
    Content Partners